247 related articles for article (PubMed ID: 17016854)
1. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.
Galvao J; Elvas F; Martins T; Cordeiro MF; Ambrósio AF; Santiago AR
Exp Eye Res; 2015 Nov; 140():65-74. PubMed ID: 26297614
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.
Mulloy DP; Sharma AK; Fernandez LG; Zhao Y; Lau CL; Kron IL; Laubach VE
Ann Thorac Surg; 2013 May; 95(5):1762-7. PubMed ID: 23541429
[TBL] [Abstract][Full Text] [Related]
4. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A3 receptor agonist reduces early brain injury in subarachnoid haemorrhage.
Luo C; Yi B; Tao G; Li M; Chen Z; Tang W; Zhang JH; Feng H
Neuroreport; 2010 Sep; 21(13):892-6. PubMed ID: 21150487
[TBL] [Abstract][Full Text] [Related]
7. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
8. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
Tian Y; Marshall M; French BA; Linden J; Yang Z
Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
[TBL] [Abstract][Full Text] [Related]
9. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
Mlejnek P; Dolezel P; Frydrych I
J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
[TBL] [Abstract][Full Text] [Related]
10. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
Hussain A; Gharanei AM; Nagra AS; Maddock HL
Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
[TBL] [Abstract][Full Text] [Related]
11. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.
Dunwiddie TV; Diao L; Kim HO; Jiang JL; Jacobson KA
J Neurosci; 1997 Jan; 17(2):607-14. PubMed ID: 8987783
[TBL] [Abstract][Full Text] [Related]
12. Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart.
Hochhauser E; Kaminski O; Shalom H; Leshem D; Shneyvays V; Shainberg A; Vidne BA
Antioxid Redox Signal; 2004 Apr; 6(2):335-44. PubMed ID: 15025935
[TBL] [Abstract][Full Text] [Related]
13. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.
Auchampach JA; Rizvi A; Qiu Y; Tang XL; Maldonado C; Teschner S; Bolli R
Circ Res; 1997 Jun; 80(6):800-9. PubMed ID: 9168782
[TBL] [Abstract][Full Text] [Related]
14. Cl-IB-MECA enhances TNF-α release in peritoneal macrophages stimulated with LPS.
Forte G; Sorrentino R; Montinaro A; Pinto A; Morello S
Cytokine; 2011 May; 54(2):161-6. PubMed ID: 21354814
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.
Safran N; Shneyvays V; Balas N; Jacobson KA; Nawrath H; Shainberg A
Mol Cell Biochem; 2001 Jan; 217(1-2):143-52. PubMed ID: 11269659
[TBL] [Abstract][Full Text] [Related]
16. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
[TBL] [Abstract][Full Text] [Related]
17. A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells.
Ge ZD; van der Hoeven D; Maas JE; Wan TC; Auchampach JA
J Mol Cell Cardiol; 2010 Aug; 49(2):280-6. PubMed ID: 20132822
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII.
Yuan K; Bai GY; Park WH; Kim SZ; Kim SH
Peptides; 2008 Dec; 29(12):2216-24. PubMed ID: 18838091
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.
Shneyvays V; Nawrath H; Jacobson KA; Shainberg A
Exp Cell Res; 1998 Sep; 243(2):383-97. PubMed ID: 9743598
[TBL] [Abstract][Full Text] [Related]
20. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
